Home
>
News & events
>
Latest news
Latest news
Treatments
MINIject®
Clinical program
Publications
Glaucoma
About glaucoma
Glaucoma surgery & treatments
News & events
Latest news
Press releases
Upcoming events
Multimedia gallery
iSTAR Medical
About us
Management team
Board of directors
Scientific advisors
Careers
Contact
en
Home
Treatments
Glaucoma
News & events
iSTAR Medical
Careers
Contact
MINIject®
Clinical program
Publications
About glaucoma
Glaucoma surgery & treatments
Latest news
Press releases
Upcoming events
Multimedia gallery
About us
Management team
Board of directors
Scientific advisors
Latest news
Press releases
Upcoming events
Multimedia gallery
News archive
All years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
All years
All years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Press releases
26th November 2021
Belgian med-tech innovator iSTAR Medical secures €20 million European financing from the EIB
READ MORE
Press releases
17th November 2021
iSTAR Medical receives European market approval for glaucoma implant MINIject
READ MORE
News
15th November 2021
MINIject results presented at the AAO meeting
READ MORE
Press releases
12th November 2021
iSTAR Medical present final results from STAR-II European trial for MINIject in glaucoma patients at AAO
READ MORE
News
9th November 2021
MINIject in Glaucoma Today
READ MORE
News
20th October 2021
CEO Michel Vanbrabant to present at OIS Glaucoma virtual 2021
READ MORE
News
8th October 2021
MINIjectTM longer-term data at ESCRS
READ MORE
News
6th October 2021
MINIject’s data presented at European Ophthalmology Futures Forum, Virtual 2021
READ MORE
News
6th October 2021
iSTAR Medical’s Supraciliary MIGS presented at IGC
READ MORE
News
2nd October 2021
Preliminary, interim, three-year MINIjectTM data show strong performance and no ECD safety concerns
READ MORE
News
30th September 2021
MINIjectTM data featuring at German DOG virtual meeting
READ MORE
Press releases
29th July 2021
iSTAR Medical recruits Paul van Hagen as CFO
READ MORE
1
2
Sign up to receive company news alerts
E-mail address
Subscribe
×